Amber Sunesara
Family · Houston, TXNPI 1700494671
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 640 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 84.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $2,786 and has fallen 92.0% since, to $223 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 640 payments — averaging $9.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Nalu Medical, Inc.$801
- Saluda Medical Americas, Inc.$30
- Vertos Medical, Inc.$25
- Pacira Pharmaceuticals Incorporated$24
- Nevro Corp.$22
- plus $17 from 1 others
What the payments were for
- Food & beverage$5,68295%
- Education$2825%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 566 | $5,045 |
| Nalu Medical, Inc. | 69 | $801 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Vertos Medical, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Nevro Corp. | 1 | $22 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,964 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 364 | $5,065 |
| Lidocaine | 20 | $2,741 |
| Celecoxib | 81 | $1,940 |
| Tizanidine Hcl | 123 | $1,367 |
| Methocarbamol | 88 | $870 |
| Diclofenac Sodium | 11 | $401 |
| Cyclobenzaprine Hcl | 39 | $391 |
| Baclofen | 34 | $356 |
| Duloxetine Hcl | 16 | $197 |
| Amitriptyline Hcl | 16 | $131 |
| Ropinirole Hcl | 24 | $102 |
| Meloxicam | 12 | $75 |
| Ibuprofen | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other family in Houston
- Robin BeachHouston$428K
- Sarah AguilarHouston$199K
- Margaret WhiteHouston$85K
- Cheryl HaseebHouston$42K
- Kendrick ClackHouston$28K
- David WeirDallas$959K
- April LopezMcAllen$417K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.